Latest Articles

Publication Date
All News Scientific
Sacituzumab Tirumotecan Improves Survival in Advanced Endometrial Cancer - Targeted Oncology

Sacituzumab Tirumotecan Improves Survival in Advanced Endometrial Cancer Targeted Oncology

Published: May 18, 2026, 1:33 p.m.
Read Full Article
Merck endometrial cancer drug meets survival goals in phase 3 trial - StreetInsider

Merck endometrial cancer drug meets survival goals in phase 3 trial StreetInsider

Published: May 18, 2026, 10:47 a.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Business Wire

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Business Wire

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Yahoo! Finance Canada

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Yahoo! Finance …

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes - The American Journal of Managed Care® (AJMC®)

Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes The American Journal of Managed Care® (AJMC®)

Published: May 12, 2026, 7:56 p.m.
Read Full Article
Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes - The American Journal of Managed Care

Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes The American Journal of Managed Care

Published: May 12, 2026, 7:56 p.m.
Read Full Article
Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop it Have Better Survival Outcomes - The American Journal of Managed Care® (AJMC®)

Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop it Have Better Survival Outcomes The American Journal of Managed Care® (AJMC®)

Published: May 12, 2026, 7:52 p.m.
Read Full Article
Impact of Overall Survival Data on Immunotherapy Selection in Endometrial Cancer - Pharmacy Times

Impact of Overall Survival Data on Immunotherapy Selection in Endometrial Cancer Pharmacy Times

Published: April 17, 2026, 12:30 p.m.
Read Full Article
Low-Risk Endometrial Cancer: Does a Lack of Adjuvant Therapy Affect Survival? - The ASCO Post

Low-Risk Endometrial Cancer: Does a Lack of Adjuvant Therapy Affect Survival? The ASCO Post

Published: April 2, 2026, 4:19 p.m.
Read Full Article
Endo together: Stories of strength, survival & sisterhood - MSN

Endo together: Stories of strength, survival & sisterhood MSN

Published: March 31, 2026, 4:30 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!